Agios Pharmaceuticals
AGIO
#4943
Rank
C$2.83 B
Marketcap
C$47.49
Share price
-1.52%
Change (1 day)
-9.76%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -C$0.66 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are C$66.04 Million. In 2025 the company made an earning of -C$0.67 Billion a decrease over its 2024 earnings that were of -C$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.66 Billion-1.63%
2025 -C$0.67 Billion10.9%
2024 -C$0.61 Billion8.75%
2023 -C$0.56 Billion0.63%
2022 -C$0.55 Billion2.81%
2021 -C$0.54 Billion10.58%
2020 -C$0.49 Billion-18.41%
2019 -C$0.6 Billion15.72%
2018 -C$0.52 Billion12.99%
2017 -C$0.46 Billion59.61%
2016 -C$0.29 Billion69.32%
2015 -C$0.17 Billion119.28%
2014 -C$76.36 Million39.22%
2013 -C$54.85 Million69.1%
2012 -C$32.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.93 B-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.90 B-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$14.12 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-C$0.24 Billion-64.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$1.41 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA